Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Net Debt Issuances and Repayments (2012 - 2026)

Updated

Phibro Animal Health (PAHC) recorded Net Debt Issuances and Repayments of $142.74 million in fiscal Q1 2027 (quarter ended Sep 30, 2026), up 74.2% from $81.94 million a year earlier and up 98.4% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Net Debt Issuances and Repayments (2012 - 2026) Analysis & Trends

On a TTM basis, Phibro Animal Health's Net Debt Issuances and Repayments came in at $568.88 million as of Sep 30, 2026, down 25.0% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $289.16 million, down 66.6% from FY2025.

  • Annual Net Debt Issuances and Repayments has a five-year compound annual growth rate of -6.1% (FY2021 to FY2026).
  • Across earlier fiscal years, Net Debt Issuances and Repayments came in at $864.52 million in FY2025 (-27.0%), $1.18 billion in FY2024 (+273.3%), $317.04 million in FY2023 (+10.2%) and $287.63 million in FY2022 (-27.5%).
  • Quarterly Net Debt Issuances and Repayments has ranged from $36.9 million in fiscal Q2 2024 to $846.02 million in fiscal Q3 2024 over the past five years.
  • On a year-over-year basis, Net Debt Issuances and Repayments has increased for three consecutive quarters, with an average decline of 10.8% over the last seven quarters.
  • Peak year-over-year performance for Net Debt Issuances and Repayments in the last five years was growth of 799.0% in fiscal Q3 2024, against a decline of 87.9% in fiscal Q2 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $71.94 million (Q4 2026), $296.26 million (Q3 2026) and $57.94 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.28 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.48 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -682.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.91 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -87.00 Mn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 142.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 142.74 Mn
Jun 30, 2026 71.94 Mn
Mar 31, 2026 296.26 Mn
Dec 31, 2025 57.94 Mn
Sep 30, 2025 81.94 Mn
Jun 30, 2025 48.94 Mn
Mar 31, 2025 148.06 Mn
Dec 31, 2024 479.13 Mn
Sep 30, 2024 251.99 Mn
Jun 30, 2024 119.92 Mn
Mar 31, 2024 846.02 Mn
Dec 31, 2023 36.90 Mn
Sep 30, 2023 45.90 Mn
Jun 30, 2023 81.15 Mn
Mar 31, 2023 94.11 Mn
Dec 31, 2022 131.15 Mn
Sep 30, 2022 70.25 Mn
Jun 30, 2022 78.25 Mn
Mar 31, 2022 101.75 Mn
Dec 31, 2021 75.13 Mn
API Access

Phibro Animal Health Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=PAHC&period=max&api_key=YOUR_API_KEY